Gamma sterilization in the pharma industry, 20 years of experience

Bruno Tissier, France


PhD Pharmaceutical Science Paris V Sorbonne, IAE, CPA-HEC, Certified Quality Auditor, former Vice President of a EU Pharmaceutical lab, in charge of high technology injectable manufacturing.

During his career, he developed, qualified and registered numerous pharmaceutical injectable drugs terminally sterilized by gamma irradiation and marketed in all major countries, including the EU, the US , Japan and China.

Food irradiation success story: Use for phytosanitary purpose

Murray Lynch, Australia

CEO, Steritech

Murray holds an Executive MBA with Melbourne University. Murray commenced with Steritech in 1981 and has held various positions during this time ranging from Plant Operator, Quality Assurance Manager and General Manager.

As CEO of Steritech, Murray Lynch played a leading role in the use of irradiation as a phytosanitary treatment and understands well the interactions between the growers, the packers, the traders, the retailers and the final customers.

Patient-centric sterilization

Byron J. Lambert, USA

Sr. Associate Research Fellow, Sterilization Science, Abott

Byron has been with Abbott for 28 years. He has worked in Quality, R&D and Operations and is currently a Sr. Associate Research Fellow, Sterilization Science. His current sterilization responsibilities focus on developing terminal sterilization solutions for sensitive combination devices. He has published numerous journal articles and book chapters and is a Director of the International Irradiation Association (iia). His Ph.D. is in Chemical Engineering, radiation and polymer science, under Joseph Silverman at the University of Maryland.

Byron is active in exploring novel sterilization technologies and in developing new regulatory paradigms focused on patient risk. He is a member of ISO TC198 WG15, Assurance of Sterility, and co-chair of AAMI WG15, Assurance of Sterility. He is convener of ISO TC198 WG2, Radiation Sterilization, and former co-chair of AAMI WG96, Compatibility of Materials Subject to Sterilization.

New opportunities in radiation crosslinking

Andreas Ostrowicki, Germany

CEO of BGS Beta-Gamma-Service GmbH & Co KG

Since 2008, Dr. Andreas Ostrowicki is CEO of BGS Beta-Gamma-Service GmbH & Co KG, Germany’s biggest provider of radiation services and one of the forerunners of the industrial application of radiation crosslinking.

Born 2.2.1963 in Bonn, Germany, Dr. Andreas Ostrowicki studied chemistry at Rheinische Friedrich-Wilhelm-University in Bonn, obtaining his doctorate in 1989. In 2007, he completed a second diploma in “Applied Management“at the renowned Warwick Business School in UK.

Ostrowicki joined Bayer AG in 1990, assuming various positions in Germany, Canada and Finland. 2003 he became managing director of PolymerLatex, a joint venture of Bayer AG and Hüls AG in Great Britain.

He joined BGS Beta-Gamma-Service GmbH & Co. KG 2008 and developed the business to one of the leading service providers for radiation sterilisation and radiation crosslinking in Europe.


Radiation landscape in the Americas

Phil Macnabb, USA

President Sterigenics

Philip Macnabb is currently President of Sterigenics, a Sotera Health company. Philip joined Sterigenics as CFO in October of 2011 then assumed the COO role in November of 2013. Subsequent to the acquisitions of Nordion and Nelson Labs, Sterigenics re-organized into three business units under the holding company umbrella of Sotera Health which holds businesses that are focused on safeguarding global health. Philip has full oversight of the Sterigenics Sterilization Services business which includes 46 facilities in 13 countries around the world. Philip has worked in various industries of both private and public companies including healthcare, consumer products, distribution, and computer hardware. He spent three years as an expatriate in Mexico and is fluent in Spanish. Philip received an MBA from the University of Chicago, and a BS in Business Administration from Purdue University.

The challenges and opportunities for sterilization in Europe

Michael Eaton, United Kingdom

Leader contract sterilization outside USA, STERIS

Mike Eaton, based in the UK, is a graduate in biology with a Master degree in business administration. His professional career spans 23 years starting in research/technical/quality roles and later moving into general management. He has 18 years of experience within STERIS (formerly Synergy Health) providing contract sterilization services to the Pharma and Medical Device industries. His current role at STERIS is to lead the contract sterilization business outside of the US, with the main focus in Europe and Asia.


Kenneth Hsiao, China

CEO of CGN Dasheng Electron Accelerator Technology

As CEO of CGN Dasheng Electron Accelerator Technology (since August 2015), Kenneth Hsiao in charge of strategic planning & management of the company. Before 2015, Kenneth Hsiao was the president of Jiangsu Dasheng Electron Accelerator Manufacturer Co.,Ltd (since December 2010).


Low energy electron beam – A new solution for the dry food industry.

Nicolás Meneses, Ph.D., Switzerland

Head of Low Energy Electron Beam, Bühler AG

Head of Low Energy Electron Beam. Responsible of implementation and commercialization of a breakthrough microbial reduction papers.


Superconducting accelerator: latest developments

Jayakar Thangaraj, USA

Science & Technology Manager and Deputy Director, Illinois Accelerator Research Center (IARC)

Jayakar “Charles” Tobin Thangaraj is currently the science and technology manager and the deputy director at the Illinois Accelerator Research Center (IARC). Charles works at the frontiers of accelerator science where bold ideas enable discoveries that transform our fundamental understanding of the universe. He is passionate about partnership between science, technology and startups to enable entrepreneurship and innovation to solve 21st century challenges in environment, medicine and society. He received both his M.S. and PhD from the University of Maryland. Charles joined Fermilab as a People’s Fellow in 2009.


Mathematical modelling of product dose in the gamma irradiator process

Chris Howard, Canada

Nordion and Sotera Health’s sister companies

Chris supports gamma technologies at Nordion and Sotera Health’s sister companies. At Nordion, he is involved in cobalt source production, Nordion Engineering and irradiator design, and cobalt source load planning. He also supports the radiation process community as a member of ISO and ASTM. He specializes in modeling dosimetry and dose to product in self-contained and industrial scale gamma irradiators. Chris holds an Masters degree from Queen’s University and a PhD from the University of Alberta.